Carlsmed, Inc. (CARL)
$14.47-2.10%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $393M
- Beta
- 2.09
- P/E (TTM)
- -10.64
- Short % float
- 11.63%
- Days to cover
- 14.3
- SI change
- -2.3%
- 1W
- -1.16%
- 1M
- -5.67%
- vs SPY 1W
- -1.02%
- vs SPY 1M
- -8.18%
Industry peers
FMP comparable companies · ranked by market cap
- ISRGBUYIntuitive Surgical, Inc.$149.1BRECOVERYQ 29$422.06-1.30%
- ATECBUYAlphatec Holdings, Inc.$1.7BRECOVERYQ -0$10.82-3.82%
- ENOVSELLEnovis Corporation$1.1BRECOVERYQ 0$18.99+4.05%
- SIBNBUYSI-BONE, Inc.$873MBULLQ 5$19.68-2.09%
- KIDSSELLOrthoPediatrics Corp.$563MRECOVERYQ 10$21.93-0.68%
- SSIISELLSS Innovations International, Inc.$510MCRISISQ 15$2.55+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CARL?
- LOPJLB’s latest quantitative signal on Carlsmed, Inc. (CARL) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CARL in?
- Carlsmed, Inc. (CARL) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Carlsmed, Inc. (CARL) do?
- Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, an…